Q97726806

Summary

Q97726806 is an individual motion^[1].

Key Facts

• Q97726806 authored Finn Bengtsson^[2].
• Q97726806's instance of is recorded as individual motion^[3].
• Q97726806's part of the series is recorded as motions of 2017-2018 legislative session of the Riksdag^[4].
• Q97726806's language of work or name is recorded as Swedish^[5].
• Q97726806 was released on +2017-10-04T00:00:00Z^[6].
• Q97726806's main subject is medication^[7].
• Q97726806's work available at URL is recorded as http://data.riksdagen.se/dokument/H5022239^[8].
• Q97726806's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H5022239^[9].
• Q97726806's applies to jurisdiction is recorded as Sweden^[10].
• Q97726806's legal citation of this text is recorded as Mot. 2017/18:2239^[11].
• Q97726806's title is recorded as Läkemedel vid sällsynta sjukdomar^[12].
• Q97726806's maintained by WikiProject is recorded as Project Riksdagen's documents^[13].
• Q97726806's copyright status is recorded as public domain^[14].
• Q97726806's legislative committee is recorded as Committee on Health and Welfare^[15].

Body

Definition and Type

Q97726806's instance of is recorded as individual motion^[3].